Selected research
Market Outlook & Growth Opportunities
Global Acitretin Capsules Market Outlook and Growth Opportunities 2026
Market perspective
The global Acitretin Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Acitretin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Acitretin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acitretin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Acitretin Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Acitretin Capsules market include GSK, Teva, Jinlan Pharm-Drugs, HuaPont Pharm, Sun Pharma, SigmaPharm Laboratories and Prasco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Acitretin Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Acitretin Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Acitretin Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acitretin Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Acitretin Capsules Segment by Company
GSK
Teva
Jinlan Pharm-Drugs
HuaPont Pharm
Sun Pharma
SigmaPharm Laboratories
Prasco
Acitretin Capsules Segment by Type
10mg
17.5mg
25mg
Others
Acitretin Capsules Segment by Application
Hospital
Clinic
Others
Acitretin Capsules Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Acitretin Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Acitretin Capsules market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Acitretin Capsules significant trends, drivers, influence factors in global and regions.
6. To analyze Acitretin Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acitretin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acitretin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acitretin Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Acitretin Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acitretin Capsules industry.
Chapter 3: Detailed analysis of Acitretin Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Acitretin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Acitretin Capsules in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 17.5mg
- 25mg
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- GSK
- Teva
- Jinlan Pharm-Drugs
- HuaPont Pharm
- Sun Pharma
- SigmaPharm Laboratories
- Prasco
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Acitretin Capsules Sales Value (2021-2032)
- 1.2.2 Global Acitretin Capsules Sales Volume (2021-2032)
- 1.2.3 Global Acitretin Capsules Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Acitretin Capsules Market Dynamics
- 2.1 Acitretin Capsules Industry Trends
- 2.2 Acitretin Capsules Industry Drivers
- 2.3 Acitretin Capsules Industry Opportunities and Challenges
- 2.4 Acitretin Capsules Industry Restraints
3 Acitretin Capsules Market by Company
- 3.1 Global Acitretin Capsules Company Revenue Ranking in 2025
- 3.2 Global Acitretin Capsules Revenue by Company (2021-2026)
- 3.3 Global Acitretin Capsules Sales Volume by Company (2021-2026)
- 3.4 Global Acitretin Capsules Average Price by Company (2021-2026)
- 3.5 Global Acitretin Capsules Company Ranking (2024-2026)
- 3.6 Global Acitretin Capsules Company Manufacturing Base and Headquarters
- 3.7 Global Acitretin Capsules Company Product Type and Application
- 3.8 Global Acitretin Capsules Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Acitretin Capsules Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Acitretin Capsules Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Acitretin Capsules Market by Type
- 4.1 Acitretin Capsules Type Introduction
- 4.1.1 10mg
- 4.1.2 17.5mg
- 4.1.3 25mg
- 4.1.4 Others
- 4.2 Global Acitretin Capsules Sales Volume by Type
- 4.2.1 Global Acitretin Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Acitretin Capsules Sales Volume by Type (2021-2032)
- 4.2.3 Global Acitretin Capsules Sales Volume Share by Type (2021-2032)
- 4.3 Global Acitretin Capsules Sales Value by Type
- 4.3.1 Global Acitretin Capsules Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Acitretin Capsules Sales Value by Type (2021-2032)
- 4.3.3 Global Acitretin Capsules Sales Value Share by Type (2021-2032)
5 Acitretin Capsules Market by Application
- 5.1 Acitretin Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Acitretin Capsules Sales Volume by Application
- 5.2.1 Global Acitretin Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Acitretin Capsules Sales Volume by Application (2021-2032)
- 5.2.3 Global Acitretin Capsules Sales Volume Share by Application (2021-2032)
- 5.3 Global Acitretin Capsules Sales Value by Application
- 5.3.1 Global Acitretin Capsules Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Acitretin Capsules Sales Value by Application (2021-2032)
- 5.3.3 Global Acitretin Capsules Sales Value Share by Application (2021-2032)
6 Acitretin Capsules Regional Sales and Value Analysis
- 6.1 Global Acitretin Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Acitretin Capsules Sales by Region (2021-2032)
- 6.2.1 Global Acitretin Capsules Sales by Region: 2021-2026
- 6.2.2 Global Acitretin Capsules Sales by Region (2027-2032)
- 6.3 Global Acitretin Capsules Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Acitretin Capsules Sales Value by Region (2021-2032)
- 6.4.1 Global Acitretin Capsules Sales Value by Region: 2021-2026
- 6.4.2 Global Acitretin Capsules Sales Value by Region (2027-2032)
- 6.5 Global Acitretin Capsules Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Acitretin Capsules Sales Value (2021-2032)
- 6.6.2 North America Acitretin Capsules Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Acitretin Capsules Sales Value (2021-2032)
- 6.7.2 Europe Acitretin Capsules Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Acitretin Capsules Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Acitretin Capsules Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Acitretin Capsules Sales Value (2021-2032)
- 6.9.2 South America Acitretin Capsules Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Acitretin Capsules Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Acitretin Capsules Sales Value Share by Country, 2025 VS 2032
7 Acitretin Capsules Country-level Sales and Value Analysis
- 7.1 Global Acitretin Capsules Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Acitretin Capsules Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Acitretin Capsules Sales by Country (2021-2032)
- 7.3.1 Global Acitretin Capsules Sales by Country (2021-2026)
- 7.3.2 Global Acitretin Capsules Sales by Country (2027-2032)
- 7.4 Global Acitretin Capsules Sales Value by Country (2021-2032)
- 7.4.1 Global Acitretin Capsules Sales Value by Country (2021-2026)
- 7.4.2 Global Acitretin Capsules Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.9.2 France Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.16.2 China Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.19.2 India Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Acitretin Capsules Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Acitretin Capsules Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Acitretin Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.1.4 GSK Acitretin Capsules Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Teva
- 8.2.1 Teva Company Information
- 8.2.2 Teva Business Overview
- 8.2.3 Teva Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Teva Acitretin Capsules Product Portfolio
- 8.2.5 Teva Recent Developments
- 8.3 Jinlan Pharm-Drugs
- 8.3.1 Jinlan Pharm-Drugs Company Information
- 8.3.2 Jinlan Pharm-Drugs Business Overview
- 8.3.3 Jinlan Pharm-Drugs Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Jinlan Pharm-Drugs Acitretin Capsules Product Portfolio
- 8.3.5 Jinlan Pharm-Drugs Recent Developments
- 8.4 HuaPont Pharm
- 8.4.1 HuaPont Pharm Company Information
- 8.4.2 HuaPont Pharm Business Overview
- 8.4.3 HuaPont Pharm Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.4.4 HuaPont Pharm Acitretin Capsules Product Portfolio
- 8.4.5 HuaPont Pharm Recent Developments
- 8.5 Sun Pharma
- 8.5.1 Sun Pharma Company Information
- 8.5.2 Sun Pharma Business Overview
- 8.5.3 Sun Pharma Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Sun Pharma Acitretin Capsules Product Portfolio
- 8.5.5 Sun Pharma Recent Developments
- 8.6 SigmaPharm Laboratories
- 8.6.1 SigmaPharm Laboratories Company Information
- 8.6.2 SigmaPharm Laboratories Business Overview
- 8.6.3 SigmaPharm Laboratories Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.6.4 SigmaPharm Laboratories Acitretin Capsules Product Portfolio
- 8.6.5 SigmaPharm Laboratories Recent Developments
- 8.7 Prasco
- 8.7.1 Prasco Company Information
- 8.7.2 Prasco Business Overview
- 8.7.3 Prasco Acitretin Capsules Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Prasco Acitretin Capsules Product Portfolio
- 8.7.5 Prasco Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Acitretin Capsules Value Chain Analysis
- 9.1.1 Acitretin Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Acitretin Capsules Sales Mode & Process
- 9.2 Acitretin Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Acitretin Capsules Distributors
- 9.2.3 Acitretin Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst